November 16, 2020 – Vancouver, British Columbia, Canada –Myconic Capital Corp. (formerly, Auralite Investments Inc.) (TSXV:MEDI) (CSE:MEDI) (the “Company” or “Myconic“) is pleased to announce that the Company’s common shares has been approved for listing on the Canadian Securities Exchange (the “CSE”) and is trading on the CSE under the trading symbol “MEDI”.
The Company’s common shares voluntarily delisted from the TSX Venture Exchange at the close of market on November 12, 2020, and commenced trading on the CSE on November 13, 2020. The Company’s ticker symbol remains unchanged and the transition was seamless for investors buying or selling shares.
“We are pleased to be listing on the Canadian Securities Exchange, one of Canada’s most dynamic marketplaces, which we believe allows Myconic Capital a tremendous opportunity for growth. We will continue to expand our diversified portfolio that is focused on emerging companies active in the high-tech, real estate, cannabis, mining, and health & wellness sectors.” said Robert Meister, Chief Executive Officer of Myconic.
ABOUT MYCONIC
Myconic Capital Corp is an investment issuer with a diversified portfolio that is focused on emerging companies active in the high-tech, real estate, cannabis, mining and health & wellness sectors.
On behalf of:
MYCONIC CAPITAL CORP.
“Robert Meister”
Robert Meister
Director
For further information, please contact:
Robert Meister
Tel: 604-351-6647
Or Email: rob@auraliteinvestments.com
The Canadian Securities Exchange (the “CSE”) has not reviewed and does not accept responsibility for the accuracy or adequacy of this release.
Notice Regarding Forward Looking Information:
This news release contains forward-looking statements including statements regarding any of the Myconic holdings or investments, as well other statements that are not historical facts. Readers are cautioned not to place undue reliance on forward-looking statements, as there can be no assurance that the plans, intentions or expectations upon which they are based will occur. By their nature, forward-looking statements involve numerous assumptions, known and unknown risks and uncertainties, both general and specific, that contribute to the possibility that the predictions, forecasts, projections and other forward-looking statements will not occur, which may cause actual performance and results in future periods to differ materially from any estimates or projections of future performance or results expressed or implied by such forward-looking statements. These assumptions, risks and uncertainties include, among other things, the state of the economy in general and capital markets in particular, investor interest in the business, and future prospects of the Company.
The forward-looking statements contained in this news release are made as of the date of this news release. Except as required by law, the Company disclaims any intention and assumes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable securities law. Additionally, the Company undertakes no obligation to comment on the expectations of, or statements made, by third parties in respect of the matters discussed above.